ArticleScientific reports2019

Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study.

Lauren E Mokry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.